Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database. - Wikidata - wikimedia - TriplyDB

Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database.

Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database.

http://www.wikidata.org/entity/Q35714366

about

Insulin Degludec, The New Generation Basal Insulin or Just another Basal Insulin?Insulin therapy and risk of prostate cancer: a systematic review and meta-analysis of observational studies The metabolic and mitogenic properties of basal insulin analogues The evolution of insulin glargine and its continuing contribution to diabetes care Heart failure prognosis and management in over-80-year-old patients: data from a French national observational retrospective cohort.Cancer biology in diabetes.Diabetes medications and cancer risk: review of the literature Insulin glargine and cancer risk in patients with diabetes: a meta-analysis.Glargine safety, diabetes and cancer.Electronic medical record cancer incidence over six years comparing new users of glargine with new users of NPH insulin Diabetes, glucose control, glucose lowering medications, and cancer risk: a 10-year population-based historical cohort Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies.Cancer specific mortality in insulin-treated type 2 diabetes patients.Associations between diabetes medication use and risk of second breast cancer events and mortality Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database.Insulin analogs for the treatment of diabetes mellitus: therapeutic applications of protein engineering.Design of non-standard insulin analogs for the treatment of diabetes mellitus Insulin therapy and cancer in type 2 diabetes.Glargine and cancer: can we now suggest closure?Does insulin glargine increase the risk of cancer compared with other basal insulins?: A French nationwide cohort study based on national administrative databases.A population database study of outcomes associated with vitamin K antagonists in atrial fibrillation before DOAC.The Relationship between Metformin and Cancer in Patients with Type 2 Diabetes.Impact of the 2013 French Pill Crisis on Women's Behaviour Regarding Contraception Cancer incidence among those initiating insulin therapy with glargine versus human NPH insulin.Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes.Usage patterns of 'over-the-counter' vs. prescription-strength nonsteroidal anti-inflammatory drugs in France.Diabetes and cancer relationships.Type 2 diabetes pharmacoepidemiology update 2014: safety versus efficacy.Estimating the number of sudden cardiac deaths attributable to the use of domperidone in France.Insulin glargine metabolite 21(A) -Gly-human insulin (M1) is the principal component circulating in the plasma of young children with type 1 diabetes: results from the PRESCHOOL study.The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology.The past, present and perhaps future of pharmacovigilance: homage to Folke Sjoqvist.Outcomes in patients after myocardial infarction similar to those of the PEGASUS-TIMI 54 trial: A cohort study in the French national claims database.Persistence and adherence to single-tablet regimens in HIV treatment: a cohort study from the French National Healthcare Insurance Database.Impact of clinical characteristics and management on the prognosis of unselected heart failure patients.Self-controlled case series and misclassification bias induced by case selection from administrative hospital databases: application to febrile convulsions in pediatric vaccine pharmacoepidemiology.Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France.Impact of pioglitazone regulatory withdrawal on antidiabetic drug use and health in diabetic patients.Management and cost analysis of cancer patients treated with G-CSF: a cohort study based on the French national healthcare insurance database.Report of the Japan Diabetes Society/Japanese Cancer Association Joint Committee on Diabetes and Cancer.

P2860

Q24624156-EF031355-33FE-4A29-8CA2-5FD4B486389A Q26823071-3AC68A71-206C-4033-BB88-E034145169F4 Q26991486-00D0306F-A86C-49D6-879B-5FAE8A958DBA Q26999454-AA7989AC-7DC9-4426-96D0-1451CF4E3E67 Q30881762-32F9E421-3FA5-4DEE-A116-608FD4CEBC67 Q33608038-C23C8263-10F7-47E8-8839-F5DF54B02128 Q33714881-EFB60B52-A399-4B1A-AE57-7B8CCDDE5679 Q34320632-34588CE0-7704-4AFE-80D5-A09EB33C4DFD Q34326924-F8400044-B51F-4C96-9A31-6C4816EC0F4F Q34373861-D2010251-8395-41B3-9E60-838ABD1044ED Q34392021-E2C9CD9A-648B-4572-BB18-D0D2B4A004F4 Q35038355-C9166F15-6C0A-4A7B-88BE-4C2C0B19147A Q35131192-19197404-D464-4020-98A1-BD81789E6FBA Q35850213-3CCF24EC-8CB5-4501-B392-10A4979C8B2E Q35887463-039E0D30-A1CD-4998-883A-816F6BF17113 Q35988978-7444760F-9B8E-426D-996D-32E31C462DB5 Q36374363-E2CE2850-EDA3-45A3-84F2-DD2A8E229214 Q36417868-A14A20AB-46A0-4B43-A0F8-0521291FD920 Q36426885-8A23FC0B-592D-4713-BD61-BA744FCF0BB0 Q36560372-F4E1E6DF-95AA-4A43-9755-20EFADBB493C Q36618123-6BF716FD-6A55-4B92-9C1F-EA4FA8798EAD Q36800721-D0B45783-529E-4585-BDC9-6A278EBCA891 Q36942841-0607CA40-78E4-4208-B127-4F0A8AB53437 Q37278227-405D442C-1C12-4D93-9B05-39932DCF110F Q37331188-7306A79B-25E9-4AE5-AB59-BE1E619C80DB Q37731873-C170C47A-2443-4241-A9EE-F0AE078A4902 Q38097984-B1D1AE3F-E996-410B-B817-E83802EB4D8B Q38264376-B5BEC3A8-6C04-4E7E-8FA0-02089B5B9F3A Q38400100-C5FD156F-A78F-49D7-B4EE-6705ECDA529B Q38426608-F8EFFEF3-9C81-485B-89C2-ECED272F1EB6 Q38764020-321C8DD1-113B-4CAC-AC5C-F43099B71DE9 Q39422837-313F9D8E-D025-43B0-B918-22403E3A16E2 Q40272818-53330626-B791-45C8-B5AE-26FA79469701 Q41294004-983D0896-104A-45F3-8F97-56C931531E6C Q41381001-6BA358B4-14BD-4EBC-8AC3-DD17087BB7F3 Q43848105-06C63557-D239-45FC-851E-C3AA3C56E5BB Q45371516-AD4BE8C1-6921-41D7-A228-3F87F7D95E6A Q48135712-DD3BD6B0-BAD3-4002-8156-C0497BA8A2CE Q48606842-1BBB1093-DAF9-4103-A631-B8C419DB4388 Q50488148-CAD04BBE-6973-47F3-9B73-FB0D9D774093

P2860

Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database.

http://www.wikidata.org/entity/Q35714366

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Insulin glargine and risk of c ...... Healthcare Insurance Database.

@ast

Insulin glargine and risk of c ...... Healthcare Insurance Database.

@en

type

label

Insulin glargine and risk of c ...... Healthcare Insurance Database.

@ast

Insulin glargine and risk of c ...... Healthcare Insurance Database.

@en

prefLabel

Insulin glargine and risk of c ...... Healthcare Insurance Database.

@ast

Insulin glargine and risk of c ...... Healthcare Insurance Database.

@en

P1433

Q35714366-0E7B9D14-8D01-484F-85AC-7374C70A572F

P1476

Q35714366-B8AFE296-47E8-468C-AA9D-F26AAD4E42A0

P2093

Q35714366-2658A1A9-CC77-4448-999E-16A9F1481D8C

Q35714366-39309BD6-2A82-4405-9A5C-BCCA6E1E6B3D

Q35714366-3E310463-DEA1-43B9-80E9-98D1D1CE4DBA

Q35714366-50323CC0-FD6B-4B3F-BEC7-715F2C4B5950

Q35714366-575B4F27-CFD4-45E1-B921-8338728F0360

Q35714366-6A3271F1-4A7F-4E86-911E-D898216E48BC

Q35714366-7AEB883B-19AB-4E81-8273-5DA4584AF92E

Q35714366-A433EB61-B06F-40D0-A6E4-C248BCA91A9C

Q35714366-B1F66B4F-8B36-440B-83D0-5BF3149721D5

Q35714366-E31D882C-2086-495C-902F-A8A6C7771CF4

P2860

Q35714366-09956E8B-AA74-4D07-959F-92AAA9513AB9

Q35714366-1BB3AF27-298F-4E21-B9F1-62CEBE33E6E6

Q35714366-1DC0CE21-1384-47B4-A2E4-3370204508A4

Q35714366-30564A41-AE0D-4D13-8839-08FB570858C3

Q35714366-349F0BB3-65F5-4DDF-8047-DE2E5DC9D719

Q35714366-35D54BEF-EF8B-4150-8E7C-77ADD1AB501B

Q35714366-3CF1D172-BE44-45D2-9D6A-2C8C339D0D7C

Q35714366-45177512-364E-490E-886B-57B068713CCE

Q35714366-48EF9B56-9B69-4DC4-8D50-F18E421F7D51

Q35714366-524586D9-66B7-4344-B1B9-3658C55D2CCB

P2888

Q35714366-9CE94B6C-BBAF-4694-8B49-64180051F54C

P304

Q35714366-D03CFC1B-B547-4099-923D-6D0DADDDB716

P31

Q35714366-50CDD5AB-15B6-4911-A97F-48D42F40CF31

P356

Q35714366-03C2F630-7878-4596-988B-C36074109CF6

P433

Q35714366-A9AD8B73-D46F-45B1-AB45-98684580F60B

P478

Q35714366-B9424AFD-129B-4ECA-82A7-051FDF8A2FB5

P577

Q35714366-101548DF-CE11-4C41-A788-0212AA961FBE

P5875

Q35714366-294BFB5F-8845-46E5-8020-1AAF10A86A71

P698

Q35714366-96C78F67-054D-40B6-8EEC-B8142BBF724D

P932

Q35714366-88928940-44D6-4108-BBDE-847926100057

P356

S00125-011-2429-5

P1433

P1476

Insulin glargine and risk of c ...... Healthcare Insurance Database.

@en

P2093

A Abouelfath

http://www.w3.org/2001/XMLSchema#string

A Pariente

http://www.w3.org/2001/XMLSchema#string

B Ambrosino

http://www.w3.org/2001/XMLSchema#string

C Droz

http://www.w3.org/2001/XMLSchema#string

C Dureau-Pournin

http://www.w3.org/2001/XMLSchema#string

C Le Jeunne

http://www.w3.org/2001/XMLSchema#string

H Gin

http://www.w3.org/2001/XMLSchema#string

M A Bernard

http://www.w3.org/2001/XMLSchema#string

N Moore

http://www.w3.org/2001/XMLSchema#string

P Blin

http://www.w3.org/2001/XMLSchema#string

P2860

Obesity and cancer risk: recent review and evidence

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

Could recombinant insulin compounds contribute to adenocarcinoma progression by stimulating local angiogenesis?

Long-term effects of intensive glucose lowering on cardiovascular outcomes.

Metformin and cancer occurrence in insulin-treated type 2 diabetic patients.

Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies.

Sulphonylureas and cancer: a case-control study.

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.

The effect of glycaemic control and glycaemic variability on mortality in patients hospitalized with congestive heart failure.

Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis.

P2888

s00125-011-2429-5

P304

644-653

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00125-011-2429-5

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221726895

http://www.w3.org/2001/XMLSchema#string

P698

22222504

http://www.w3.org/2001/XMLSchema#string

P932

3268990

http://www.w3.org/2001/XMLSchema#string